Although as of this week the stock has declined by more than 4% since the start of the year, there's little reason to believe ...

Eli Lilly recently announced encouraging Phase 1 results for its ovarian cancer treatment using a folate receptor alpha ...

Alexandria Real Estate offers a 7.5%+ yield and significant discounts to book value and equity versus peers. Read why ARE ...

Eli Lilly's portfolio, both within and outside its core area, makes the stock attractive. However, a recent move Eli Lilly made reveals an underrated reason why the stock has attractive prospects.

Financial Stability: Eli Lilly's balance sheet is more robust, with debt making up only 4% of equity, considerably less than ...